葡萄糖代谢通过表观基因组变化部分调节β细胞功能.
Yong Kyung Kim1, Kyu Chang Won2, Lori Sussel1
1Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Journal of diabetes investigation
|March 4, 2024
概括
胰腺β细胞中的葡萄糖代谢通过表观基因组影响基因表达. 了解这种联系是开发针对β细胞功能的新型糖尿病治疗的关键.
科学领域:
- 细胞代谢的细胞代谢.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 糖尿病研究研究 糖尿病研究
背景情况:
- 胰腺β细胞主要使用葡萄糖产生ATP,这对于细胞生存和胰岛素释放至关重要.
- 贝塔细胞表现出代谢灵活性,适应不断变化的葡萄糖水平和环境条件.
- 代谢适应可以改变细胞代谢物,影响表观基因组和基因表达.
研究的目的:
- 审查细胞代谢和胰腺β细胞表观基因组之间的复杂关系.
- 阐明糖尿病中β细胞功能障碍背后的分子机制.
- 确定潜在的治疗点,以保护β细胞功能,改善血糖控制.
主要方法:
- 关于β细胞代谢和表观遗传学研究的文献综述.
- 对将代谢变化与表观遗传修饰联系起来的分子途径的分析.
- 综合当前对糖尿病中β细胞功能障碍的理解.
主要成果:
- 贝塔细胞的代谢变化可能导致影响基因表达的表观遗传变化.
- 这些代谢-表观遗传相互作用在β细胞功能障碍的发展中起作用.
- 了解这些机制为糖尿病病原体提供了洞见.
结论:
- 代谢和表观遗传学之间的相互作用对于维持β细胞功能至关重要.
- 针对这些途径可能为糖尿病提供新的治疗策略.
- 需要进一步的研究才能充分利用这些见解用于临床应用.
相关概念视频
Glucose Homeostasis: Regulation of Blood Glucose
1.6K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.6K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Hormones Regulating Blood Glucose
3.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.3K
Cell Specific Gene Expression
13.6K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.6K
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
Hypoglycemia and Glucagon
260
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
260


